ANTX AN2 Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ 10-K/10-Q Aug 11, 2026
$3.55
· of 52w range
· above low
· to high
$1.0052w low
$7.1952w high
Market Cap (MRQ)
$129M
P/E
-3.1
EPS
$-1.16
your badges
52W Range
$1–$7
Analyst Rating
STRONG BUY
Price Target
$9
P/E
-3.1
ROE
-57.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ANTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.55
Market Cap (MRQ)
$129M
P/E
-3.1
EPS
$-1.16
ROE
-57.7%
52W Range
$1–$7
ANTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.162021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ANTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -3.15Y avg ≈-3.2 | ≈-3.2 | · | · | |
| P/B (MRQ) | 1.75Y avg ≈1.0 | ≈1.0 | 1.6 | Overvalued | |
| Price / Cash Flow | -3.35Y avg ≈-2.5 | ≈-2.5 | · | · | |
| Price / Tangible Book | 1.85Y avg ≈2.0 | ≈2.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ANTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -45.7%5Y avg ≈-46.3% | ≈-46.3% | -8.4% | Weak | |
| ROE | -57.7%5Y avg ≈-53.0% | ≈-53.0% | -22.7% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ANTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 14.3 | · | 3.3 | Strong liquidity | |
| Quick Ratio | 2.3 | · | 1.4 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-5.1%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $-0.18 | $-0.28 | 34.6% |
| March 31, 2026 | May 13, 2026 | $-0.29 | $-0.23 | -23.6% |
| Dec. 31, 2025 | $-0.29 | $-0.24 | -18.5% | |
| Sept. 30, 2025 | $-0.31 | $-0.22 | -38.1% | |
| June 30, 2025 | $-0.21 | $-0.34 | 38.2% | |
| March 31, 2025 | $-0.35 | $-0.26 | -32.1% | |
| Dec. 31, 2024 | $-0.25 | $-0.26 | 3.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $25M | $40M | $55M | $29M | $16M | |
| SG&A Expense | $13M | $14M | $15M | $13M | $5M | |
| Operating Expenses | $38M | $57M | $70M | $42M | $22M | |
| Operating Income | $-38M | $-57M | $-70M | $-42M | $-22M | |
| Interest Income | $3M | $5M | $5M | · | · | |
| Other Non-op | $1.0K | $1.0K | $43.0K | $1M | $-38.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-35M | $-51M | $-65M | $-41M | $-22M | |
| EPS (Basic) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 | |
| EPS (Diluted) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 | |
| Shares (Basic) | 30,215,747 | 29,828,227 | 23,600,107 | 15,340,134 | 2,638,197 | |
| Shares (Diluted) | 30,215,747 | 29,828,227 | 23,600,107 | 15,340,134 | 2,638,197 | |
| EBITDA | $-38M | $-57M | · | $-42M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $21M | $16M | $27M | $12M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $2M | |
| Current Assets | $60M | $86M | $111M | $99M | $60M | |
| Other Non-current Assets | $0 | $804.0K | $1M | $720.0K | · | |
| Total Assets | $62M | $92M | $139M | $103M | $65M | |
| Accounts Payable | $3M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $2M | $4M | $7M | $3M | $1M | |
| Current Liabilities | $9M | $10M | $14M | $7M | $3M | |
| Other Non-current Liabilities | $170.0K | $0 | · | · | · | |
| Total Liabilities | $9M | $10M | $14M | $7M | $3M | |
| Paid-in Capital | $294M | $288M | $279M | $185M | · | |
| Retained Earnings | $-241M | $-206M | $-154M | $-90M | $-47M | |
| AOCI | $57.0K | $31.0K | $275.0K | $-374.0K | $-27.0K | |
| Stockholders' Equity | $53M | $82M | $125M | $95M | $-47M | |
| Liabilities + Equity | $62M | $92M | $139M | $103M | $65M | |
| Shares Outstanding | 27,413,171 | 29,919,634 | 29,741,445 | 19,402,658 | 2,730,298 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $8M | $8M | $4M | $974.0K | |
| Restructuring | · | $2M | · | · | · | |
| Operating Cash Flow | $-30M | $-49M | $-53M | $-33M | $-20M | |
| Investing Cash Flow | $28M | $55M | $-43M | $-22M | $-50M | |
| Stock Issued | $86.0K | $147.0K | $366.0K | · | · | |
| Net Stock Activity | $86.0K | $147.0K | · | · | · | |
| Financing Cash Flow | $113.0K | $372.0K | $85M | $70M | $79M | |
| Net Change in Cash | $-1M | $6M | $-12M | $15M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -45.7% | -44.5% | · | -48.8% | · | |
| ROE | -57.7% | -60.6% | · | -40.8% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | · | · | 13.7 | · | |
| Quick Ratio | 2.3 | · | · | 3.8 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $1.94 | $2.74 | · | $4.92 | · | |
| Cash Flow / Share | $-0.99 | $-1.65 | · | $-2.18 | · | |
| Cash / Share | $0.73 | $0.71 | · | $1.40 | · | |
| EPS (TTM) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-35M | $-51M | $-65M | $-41M | · | |
| Market Cap | $31M | $41M | · | $185M | · | |
| P/E | -1.0 | -0.8 | -7.5 | -3.4 | · | |
| P/B | 0.6 | 0.5 | · | 1.9 | · | |
| P / Tangible Book | 0.6 | 0.5 | 4.9 | 1.9 | · | |
| P / Cash Flow | -1.0 | -0.8 | · | -5.5 | · | |
| Earnings Yield | -101.8% | -124.6% | -13.4% | -29.3% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $7M | $7M | $7M | $3M | $8M | $5M | $8M | $12M | $15M | $15M | $14M | $14M | $12M | $9M | $7M | |
| SG&A Expense | $3M | $4M | $2M | $3M | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | |
| Operating Expenses | $9M | $11M | $9M | $10M | $7M | $12M | $9M | $14M | $16M | $18M | $19M | $18M | $17M | $16M | $12M | $12M | |
| Operating Income | $-9M | $-11M | $-9M | $-10M | $-7M | $-12M | $-9M | $-14M | $-16M | $-18M | $-19M | $-18M | $-17M | $-16M | $-12M | $-12M | |
| Interest Income | $720.0K | $523.0K | $605.0K | $687.0K | $754.0K | $888.0K | $1M | $1M | $1M | $2M | · | · | · | · | · | · | |
| Other Non-op | $-1.0K | · | · | · | · | · | $-1M | $1M | $0 | $1.0K | $-3M | $1M | $797.0K | $716.0K | $634.0K | $431.0K | |
| Net Income | $-8M | $-10M | $-9M | $-9M | $-6M | $-11M | $-8M | $-13M | $-14M | $-17M | $-17M | $-17M | $-16M | $-15M | $-12M | $-11M | |
| EPS (Basic) | $-0.18 | $-0.29 | $-0.29 | $-0.31 | $-0.21 | $-0.35 | $-0.25 | $-0.43 | $-0.48 | $-0.56 | $-0.49 | $-0.65 | $-0.81 | $-0.79 | $1.31 | $-0.59 | |
| EPS (Diluted) | $-0.18 | $-0.29 | $-0.29 | $-0.31 | $-0.21 | $-0.35 | $-0.25 | $-0.43 | $-0.48 | $-0.56 | $-0.49 | $-0.65 | $-0.81 | $-0.79 | $1.31 | $-0.59 | |
| Shares (Basic) | 44,760,766 | 34,059,876 | · | 30,276,230 | 30,172,328 | 30,053,659 | · | 29,841,169 | 29,824,725 | 29,763,278 | · | 25,645,421 | 19,497,494 | 19,385,646 | · | 19,347,148 | |
| Shares (Diluted) | 44,760,766 | 34,059,876 | · | 30,276,230 | 30,172,328 | 30,053,659 | · | 29,841,169 | 29,824,725 | 29,763,278 | · | 25,645,421 | 19,497,494 | 19,385,646 | · | 19,347,148 | |
| EBITDA | $-9M | $-11M | · | $-10M | $-7M | $-12M | · | $-14M | $-16M | $-18M | · | $-18M | $-17M | $-16M | · | $-12M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $53M | $20M | $18M | $18M | $20M | $21M | $34M | $27M | $25M | $16M | $33M | $41M | $27M | $27M | $29M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $5M | $2M | $3M | $4M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | |
| Current Assets | $80M | $87M | $60M | $64M | $68M | $70M | $86M | $98M | $107M | $116M | $111M | $126M | $98M | $90M | $99M | $107M | |
| Other Non-current Assets | $216.0K | · | $0 | $0 | $0 | $304.0K | $804.0K | · | $1M | $1M | $1M | $1M | $720.0K | $720.0K | $720.0K | $720.0K | |
| Total Assets | $82M | $87M | $62M | $67M | $76M | $81M | $92M | $98M | $108M | $121M | $139M | $154M | $99M | $91M | $103M | $110M | |
| Accounts Payable | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $5M | $3M | $4M | $2M | $1M | |
| Accrued Liabilities | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $6M | $4M | $3M | $2M | |
| Current Liabilities | $6M | $6M | $9M | · | · | · | $10M | $10M | · | · | · | $15M | $11M | $9M | $7M | $4M | |
| Other Non-current Liabilities | $170.0K | $170.0K | $170.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $6M | $6M | $9M | $7M | $7M | $8M | $10M | $10M | $10M | $11M | $14M | $15M | $11M | $9M | $7M | $4M | |
| Paid-in Capital | $335M | $333M | $294M | $293M | $292M | $290M | $288M | $286M | $284M | $282M | $279M | $277M | $209M | $188M | $185M | $184M | |
| Retained Earnings | $-259M | $-251M | $-241M | $-232M | $-223M | $-216M | $-206M | $-198M | $-186M | $-171M | $-154M | $-138M | $-121M | $-105M | $-90M | $-78M | |
| AOCI | $-23.0K | $-5.0K | $57.0K | $64.0K | $25.0K | $48.0K | $31.0K | $112.0K | $-27.0K | $53.0K | $275.0K | $-122.0K | $-119.0K | $-175.0K | $-374.0K | $-541.0K | |
| Stockholders' Equity | $76M | $82M | $53M | $60M | $69M | $73M | $82M | $88M | $98M | $111M | $125M | $139M | $88M | $83M | $95M | $106M | |
| Liabilities + Equity | $82M | $87M | $62M | $67M | $76M | $81M | $92M | $98M | $108M | $121M | $139M | $154M | $99M | $91M | $103M | $110M | |
| Shares Outstanding | 36,308,669 | 35,985,599 | 27,413,171 | 27,371,154 | 27,376,461 | 30,141,517 | 29,919,634 | 29,868,583 | 29,829,040 | 29,815,663 | 29,741,445 | 29,741,445 | 21,928,452 | 19,426,452 | 19,402,658 | 19,402,658 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $972.0K | $1M | $1M | $801.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | $-9.0K | $2M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-12M | $-5M | $-6M | $-8M | $-11M | $-5M | $-12M | $-14M | $-18M | $-17M | $-12M | $-13M | $-12M | $-8M | $-9M | |
| Investing Cash Flow | $-4M | $8M | $7M | $6M | $6M | $9M | $-7M | $19M | $16M | $26M | $420.0K | $-62M | $8M | $11M | $6M | $-2M | |
| Stock Issued | · | · | $0 | $48.0K | $0 | $38.0K | $0 | $23.0K | $0 | $124.0K | $0 | $167.0K | $0 | $199.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | $38.0K | · | · | · | $124.0K | · | · | · | $199.0K | · | · | |
| Financing Cash Flow | $1M | $37M | $0 | $48.0K | $0 | $65.0K | $0 | $23.0K | $0 | $349.0K | $-321.0K | $66M | $19M | $199.0K | $0 | $-10.0K | |
| Net Change in Cash | $-9M | $34M | $2M | $-217.0K | $-2M | $-1M | $-12M | $7M | $2M | $9M | $-17M | $-8M | $14M | $-510.0K | $-2M | $-12M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.4% | -11.9% | · | -11.3% | -7.0% | -10.5% | · | -10.1% | -13.9% | -15.7% | · | -12.7% | -14.4% | -14.5% | · | -20.6% | |
| ROE | -11.3% | -12.9% | · | -12.6% | -7.7% | -11.6% | · | -11.2% | -15.5% | -17.2% | · | -13.7% | -15.5% | -15.5% | · | -21.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | 15.7 | · | · | · | · | · | 9.8 | · | · | · | 8.5 | 8.8 | 10.5 | · | 24.2 | |
| Quick Ratio | 7.9 | 9.6 | · | · | · | · | · | 3.3 | · | · | · | 2.2 | 3.7 | 3.1 | · | 6.5 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.09 | $2.27 | · | $2.21 | $2.51 | $2.43 | · | $2.94 | $3.30 | $3.71 | · | $4.67 | $4.00 | $4.25 | · | $5.44 | |
| Cash Flow / Share | · | $-0.35 | · | · | · | $-0.35 | · | · | · | $-0.59 | · | · | · | $-0.60 | · | · | |
| Cash / Share | $1.22 | $1.49 | · | $0.66 | $0.67 | $0.66 | · | $1.12 | $0.90 | $0.83 | · | $1.10 | $1.86 | $1.37 | · | $1.48 | |
| EPS (TTM) | $-1.07 | $-1.10 | · | $-1.12 | $-1.24 | $-1.51 | · | $-1.96 | $-2.18 | $-2.51 | · | $-0.94 | $-0.88 | $-0.60 | · | $-7.68 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-36M | $-35M | · | $-34M | $-37M | $-45M | · | $-61M | $-65M | $-66M | · | $-60M | $-54M | $-49M | · | $-37M | |
| Market Cap | $176M | $123M | · | $35M | $29M | $41M | · | $32M | $64M | $97M | · | $478M | $186M | $192M | · | $337M | |
| P/E | -4.5 | -3.1 | · | -1.1 | -0.9 | -0.9 | · | -0.5 | -1.0 | -1.3 | · | -17.1 | -9.7 | -16.4 | · | -2.3 | |
| P/B | 2.3 | 1.5 | · | 0.6 | 0.4 | 0.6 | · | 0.4 | 0.7 | 0.9 | · | 3.4 | 2.1 | 2.3 | · | 3.2 | |
| P / Tangible Book | 2.3 | 1.5 | · | 0.6 | 0.4 | 0.6 | · | 0.4 | 0.7 | 0.9 | · | 3.4 | 2.1 | 2.3 | · | 3.2 | |
| P / Cash Flow | · | -10.2 | · | · | · | -3.9 | · | · | · | -5.5 | · | · | · | -16.5 | · | · | |
| Earnings Yield | -22.1% | -32.2% | · | -88.2% | -117.0% | -111.0% | · | -183.2% | -101.4% | -77.2% | · | -5.9% | -10.3% | -6.1% | · | -44.2% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-35M | $-51M | $-65M | $-41M | $-22M |
| Diluted EPS | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 6.9 | · | · | 13.7 | · |
| Quick Ratio | 2.3 | · | · | 3.8 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 72 filers · $120.4M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
72
Value held
$120.4M
New positions
29
Exited positions
14
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 29 (+5 vs prior Q) | 14 (+6 vs prior Q) | 15 (+2 vs prior Q) | 13 (+5 vs prior Q) | +3.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Vivo Capital, LLC | $15,263,618 | 3,153,640 | 12.68% | Shares |
| Commodore Capital LP | $14,199,011 | 2,933,680 | 11.79% | Shares |
| MILLENNIUM MANAGEMENT LLC | $11,222,469 | 2,318,692 | 9.32% | Shares |
| BlackRock, Inc. | $8,060,991 | 1,665,494 | 6.69% | Shares |
| Spruce Street Capital LP | $8,039,593 | 1,661,073 | 6.68% | Shares |
| Almitas Capital LLC | $7,110,584 | 1,469,129 | 5.90% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $5,995,332 | 1,238,705 | 4.98% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4,840,000 | 1,000,000 | 4.02% | Shares |
| CITADEL ADVISORS LLC | $4,607,665 | 951,997 | 3.83% | Shares |
| Boxer Capital Management, LLC | $3,625,329 | 749,035 | 3.01% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $3,378,664 | 697,806 | 2.81% | Shares |
| SummitTX Capital, L.P. | $2,891,673 | 597,453 | 2.40% | Shares |
| Balyasny Asset Management L.P. | $2,691,171 | 556,027 | 2.23% | Shares |
| Stonepine Capital Management, LLC | $2,670,190 | 551,692 | 2.22% | Shares |
| AMERIPRISE FINANCIAL INC | $2,599,390 | 537,064 | 2.16% | Shares |
| Sio Capital Management, LLC | $2,564,876 | 529,933 | 2.13% | Shares |
| Ally Bridge Group (NY) LLC | $2,547,365 | 526,315 | 2.12% | Shares |
| Prosight Management, LP | $2,297,248 | 474,638 | 1.91% | Shares |
| Woodline Partners LP | $2,225,456 | 459,805 | 1.85% | Shares |
| STATE STREET CORP | $1,508,154 | 311,602 | 1.25% | Shares |
| VANGUARD GROUP INC | $1,231,280 | 1,080,070 | 1.02% | Shares |
| NORTHERN TRUST CORP | $1,040,217 | 214,921 | 0.86% | Shares |
| Seven Fleet Capital Management LP | $1,011,299 | 208,946 | 0.84% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $953,093 | 196,920 | 0.79% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $869,235 | 179,594 | 0.72% | Shares |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $810,438 | 167,446 | 0.67% | Shares |
| BANK OF AMERICA CORP /DE/ | $705,686 | 145,803 | 0.59% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $627,748 | 129,700 | 0.52% | Shares |
| GOLDMAN SACHS GROUP INC | $425,596 | 87,933 | 0.35% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $368,058 | 76,045 | 0.31% | Shares |
| UBS Group AG | $358,576 | 74,086 | 0.30% | Shares |
| Walleye Capital LLC | $349,153 | 72,139 | 0.29% | Shares |
| Bank of New York Mellon Corp | $327,552 | 67,676 | 0.27% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $310,825 | 64,220 | 0.26% | Shares |
| TWO SIGMA ADVISERS, LP | $301,986 | 264,900 | 0.25% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $289,916 | 59,900 | 0.24% | Shares |
| ADAR1 Capital Management, LLC | $284,631 | 58,808 | 0.24% | Shares |
| MORGAN STANLEY | $238,995 | 49,379 | 0.20% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $194,399 | 40,165 | 0.16% | Shares |
| Velan Capital Investment Management LP | $193,600 | 40,000 | 0.16% | Shares |
| Nuveen, LLC | $171,012 | 35,333 | 0.14% | Shares |
| DEUTSCHE BANK AG\ | $125,056 | 25,838 | 0.10% | Shares |
| RHUMBLINE ADVISERS | $117,810 | 24,342 | 0.10% | Shares |
| WELLS FARGO & COMPANY/MN | $108,363 | 22,389 | 0.09% | Shares |
| TWO SIGMA INVESTMENTS, LP | $77,019 | 15,913 | 0.06% | Shares |
| Invesco Ltd. | $66,981 | 13,839 | 0.06% | Shares |
| LPL Financial LLC | $59,774 | 12,350 | 0.05% | Shares |
| CITIGROUP INC | $59,373 | 12,267 | 0.05% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $58,980 | 12,186 | 0.05% | Shares |
| JPMORGAN CHASE & CO | $55,184 | 10,971 | 0.05% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| BML Investment Partners, L.P. ×3 filings | June 18, 2025 | 1.40% | Amendment | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 19 insiders · 9 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Eric Easom | Chief Executive Officer | March 19, 2026 D | 368,630 | 0 | 0 | $0 |
| Lucy Day | Chief Financial Officer | March 19, 2026 D | 118,363 | 0 | 2 | $-8,862 |
| Cameron C. Trenor III | Chief Medical Officer | Sept. 15, 2026 A | 116,667 | 0 | 0 | $0 |
| Sarah Joanne Williams | Principal Accounting Officer | Sept. 1, 2026 S | 66,311 | 0 | 3 | $-3,025 |
| Sanjay Chanda | Chief Development Officer | March 19, 2026 D | 118,823 | 0 | 2 | $-9,311 |
| Stephen David Prior | Chief Strategy Officer | Jan. 6, 2026 S | 59,086 | 0 | 3 | $-7,363 |
| Kevin Michael Krause | Chief Strategy Officer | March 15, 2024 A | 31,914 | 0 | 0 | $0 |
| Paul Eckburg | Chief Medical Officer | March 15, 2024 A | 51,416 | 0 | 0 | $0 |
| Michael Adrian Nazak | Chief Accounting Officer | Feb. 15, 2023 A | · | 0 | 0 | $0 |
| Gilbert Lynn Marks | Director | Oct. 12, 2026 A | 84,156 | 0 | 0 | $0 |
| Patricia A. Martin | Director | Oct. 12, 2026 A | 19,252 | 0 | 0 | $0 |
| Kabeer Aziz | Director | Oct. 12, 2026 A | 61,571 | 0 | 0 | $0 |
| Robin Shane Readnour | Director | Sept. 9, 2026 S | 624,765 | 0 | 8 | $-316,777 |
| Margaret M Fitzpatrick | Director | Sept. 1, 2026 P | 10,708 | 1 | 0 | $11,602 |
| Stephanie Wong | Director | March 19, 2026 D | · | 0 | 0 | $0 |
| Melvin K Spigelman | Director | March 19, 2026 D | · | 0 | 0 | $0 |
| Joseph S Zakrzewski | · | Aug. 14, 2026 G | 0 | 0 | 0 | $0 |
| Joshua M Eizen | · | July 8, 2026 S | 206,554 | 0 | 4 | $-52,928 |
| Leonard Braden Michael | · | May 28, 2025 S | 3,017,432 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 12 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.04% | 88,265 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 20,384 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.00% | 592,077 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.00% | 29,625 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 35,294 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 360,114 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 853,017 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 153,011 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,321 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,878 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 3,416 NS | July 31, 2026 | N-PORT |
| IWN · iShares Trust | · | 194,285 SH | Sept. 11, 2026 | Daily |
ANTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$9.00
+153.5%
4 50.0%
Strong Buy
3 37.5%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-10-24Mean target $9.00 +153.5%
Low$9.00
Mean$9.00
High$9.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ANTX | $31M | -1.0 | · | · | -57.7% | · |
| YARW | · | · | · | · | · | · |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| DERM | · | -16.4 | 10.2% | -18.5% | -44.7% | · |
| CPIX | $60M | -20.9 | 17.6% | -6.4% | -11.9% | · |
| NRXP | · | · | · | · | · | · |
| LENZ | $502M | -5.6 | · | -430.2% | -33.5% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026